D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 52 Citations 6,568 81 World Ranking 9250 National Ranking 737

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Gene expression

His primary areas of investigation include Epstein–Barr virus, Virology, Virus, Antigen and Molecular biology. His Epstein–Barr virus research is multidisciplinary, incorporating perspectives in B cell, Gene, Lymphoma, Lytic cycle and Gammaherpesvirinae. His Virology study combines topics from a wide range of disciplines, such as Gene expression and Pathogenesis.

His Virus research focuses on Virus latency in particular. His Antigen research focuses on Epstein–Barr virus infection and how it relates to Cell biology. The study incorporates disciplines such as Promoter, Transcription, Binding site and Effector in addition to Molecular biology.

His most cited work include:

  • Stringent spacing requirements for transcription activation by CRP. (212 citations)
  • Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2 (199 citations)
  • Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma (148 citations)

What are the main themes of his work throughout his whole career to date?

Andrew I. Bell mostly deals with Epstein–Barr virus, Virology, Virus, Molecular biology and Immunology. He has included themes like Virus latency, Cancer research, B cell, Lytic cycle and Gammaherpesvirinae in his Epstein–Barr virus study. His research in Virology intersects with topics in Gene expression, T cell, Germinal center, Antigen and Immunoglobulin D.

His research integrates issues of Burkitt's lymphoma, Lymphoma, Apoptosis and Pathogenesis in his study of Virus. Andrew I. Bell has researched Molecular biology in several fields, including Transcription, Transcription factor, Gene, Promoter and Binding site. His biological study spans a wide range of topics, including RNA polymerase and Escherichia coli.

He most often published in these fields:

  • Epstein–Barr virus (54.84%)
  • Virology (50.54%)
  • Virus (39.78%)

What were the highlights of his more recent work (between 2013-2021)?

  • Epstein–Barr virus (54.84%)
  • Virology (50.54%)
  • Virus (39.78%)

In recent papers he was focusing on the following fields of study:

Epstein–Barr virus, Virology, Virus, Immunology and Epstein–Barr virus infection are his primary areas of study. His work carried out in the field of Epstein–Barr virus brings together such families of science as Messenger RNA, Gene, Cell growth and Lytic cycle. Andrew I. Bell studies Virus latency which is a part of Virology.

His study in Virus is interdisciplinary in nature, drawing from both Pathogenesis, Cellular Oncogenes, Oncogene, Molecular biology and Lymphoma. The concepts of his Molecular biology study are interwoven with issues in Promoter, Response element, Transcription factor and Transcription. Andrew I. Bell focuses mostly in the field of Epstein–Barr virus infection, narrowing it down to matters related to Antibody and, in some cases, Human leukocyte antigen.

Between 2013 and 2021, his most popular works were:

  • Epstein–Barr virus-associated lymphomas (128 citations)
  • Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. (52 citations)
  • Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs. (50 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Gene expression

His primary areas of study are Virus, Epstein–Barr virus, Virology, Lymphoma and Pathogenesis. His Virus research incorporates themes from Molecular biology, Messenger RNA, Gene and Lymphocytosis. Andrew I. Bell is involved in the study of Epstein–Barr virus that focuses on Epstein–Barr virus infection in particular.

His Virology study frequently draws connections between adjacent fields such as Immunology. His Lymphoma research is multidisciplinary, incorporating elements of Oncovirus, Viral entry, Lymphatic system, Lytic cycle and Transcription. His studies in Pathogenesis integrate themes in fields like Chromosomal translocation, Cellular Oncogenes, Oncogene, Diffuse large B-cell lymphoma and Biopsy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Stringent spacing requirements for transcription activation by CRP.

Kevin Gaston;Andrew Bell;Annie Kolb;Henri Buc.
Cell (1990)

305 Citations

Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2

Gemma Kelly;Andrew Bell;Alan Rickinson.
Nature Medicine (2002)

301 Citations

Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription

Andrew Bell;Kevin Gaston;Roy Williams;Karen Chapman.
Nucleic Acids Research (1990)

230 Citations

Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.

Carol Nonkwelo;Julia Skinner;Andrew Bell;Alan Rickinson.
Journal of Virology (1996)

201 Citations

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

Gemma L. Kelly;Heather M. Long;Julianna Stylianou;Wendy A. Thomas.
PLOS Pathogens (2009)

201 Citations

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

Judith M. Timms;Andrew Bell;Joanne R. Flavell;Paul G. Murray.
The Lancet (2003)

190 Citations

Epstein–Barr virus-associated lymphomas

Claire Shannon-Lowe;Alan B. Rickinson;Andrew I. Bell.
Philosophical Transactions of the Royal Society B (2017)

187 Citations

Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells

Gemma L. Kelly;Anne E. Milner;Gouri S. Baldwin;Andrew I. Bell.
Proceedings of the National Academy of Sciences of the United States of America (2006)

186 Citations

Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.

Fiona Nitsche;Andrew Bell;Alan Rickinson.
Journal of Virology (1997)

180 Citations

Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.

Andrew I. Bell;Katherine Groves;Gemma L. Kelly;Debbie Croom-Carter.
Journal of General Virology (2006)

175 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andrew I. Bell

Stephen J. W. Busby

Stephen J. W. Busby

University of Birmingham

Publications: 55

Alan B. Rickinson

Alan B. Rickinson

University of Birmingham

Publications: 39

Henri Jacques Delecluse

Henri Jacques Delecluse

Inserm : Institut national de la santé et de la recherche médicale

Publications: 36

Christian Münz

Christian Münz

University of Zurich

Publications: 34

Jeffrey Green

Jeffrey Green

University of Sheffield

Publications: 33

Lawrence S. Young

Lawrence S. Young

University of Warwick

Publications: 29

Jeffrey A. Cole

Jeffrey A. Cole

University of Birmingham

Publications: 26

Wolfgang Hammerschmidt

Wolfgang Hammerschmidt

Ludwig-Maximilians-Universität München

Publications: 26

Richard H. Ebright

Richard H. Ebright

Rutgers, The State University of New Jersey

Publications: 25

Jaap M. Middeldorp

Jaap M. Middeldorp

VU University Medical Center

Publications: 25

Paul J. Farrell

Paul J. Farrell

Imperial College London

Publications: 22

Elliott Kieff

Elliott Kieff

Harvard University

Publications: 22

John R. Guest

John R. Guest

University of Sheffield

Publications: 21

Maher K. Gandhi

Maher K. Gandhi

University of Queensland

Publications: 20

Paul M. Lieberman

Paul M. Lieberman

The Wistar Institute

Publications: 20

Martin Rowe

Martin Rowe

University of Birmingham

Publications: 19

Trending Scientists

Peter Fitzhugh Brown

Peter Fitzhugh Brown

Renaissance Technologies

Gary K. Ackers

Gary K. Ackers

Washington University in St. Louis

Can Xue

Can Xue

Nanyang Technological University

Kurt E. Sickafus

Kurt E. Sickafus

Los Alamos National Laboratory

Hirohiko Hirochika

Hirohiko Hirochika

Institute of Agrobiological Sciences

Hiroyuki Oshiumi

Hiroyuki Oshiumi

Kumamoto University

Howard Gest

Howard Gest

Indiana University

Massimo Castagnola

Massimo Castagnola

Catholic University of the Sacred Heart

Benjamin R. Edwards

Benjamin R. Edwards

University of Liverpool

Casey Brown

Casey Brown

University of Massachusetts Amherst

Inakwu O. A. Odeh

Inakwu O. A. Odeh

University of Sydney

Ruoying He

Ruoying He

North Carolina State University

Marshall Devor

Marshall Devor

Hebrew University of Jerusalem

Ananda Nisalak

Ananda Nisalak

United States Department of the Army

Stefan Blankenberg

Stefan Blankenberg

Universität Hamburg

Ronald Boellaard

Ronald Boellaard

Vrije Universiteit Amsterdam

Something went wrong. Please try again later.